Supernus Pharmaceuticals, Inc. (SUPN) Balance Sheet
SUPN balance sheet, 2025
December 31, 2025 · U.S. dollars$1.45B assets = $390.9M liabilities + $1.06B equity
Both columns are drawn to the same scale: what SUPN owns equals what it owes plus shareholders’ equity. Hover a block for its value.
SUPN financial health
Descriptive bands, not a rating. Fiscal 2025.
SUPN balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $309.6M2016 | $1.45B2025 | +18.7%/yr | |
| Total liabilities | $117.8M2016 | $390.9M2025 | +14.3%/yr | |
| Shareholders’ equity | $191.8M2016 | $1.06B2025 | +20.9%/yr | |
| Cash & short-term investments | $90.1M2016 | $308.7M2025 | +14.7%/yr | |
| Total debt | $73.5M2016 | $41.0M2025 | −6.3%/yr | |
| Net cash (debt) | $16.6M2016 | $267.7M2025 | +$251.1M | |
| Working capital | $70.7M2016 | $306.0M2025 | +$235.3M | |
| Book value per share | $3.712016 | $18.812025 | +19.8%/yr | |
| Current ratio | 1.882016 | 1.902025 | +0.03 | |
| Debt / equity | 0.382016 | 0.042025 | −0.34 | |
| Shares outstanding | 51.7M2016 | 56.5M2025 | +1.0%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
SUPN assets
SUPN liabilities and equity
SUPN debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
SUPN balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $308.7M | $453.6M | $254.9M | $461.3M | $339.7M | $422.5M | $347.1M | $356.0M | $140.0M | $90.1M |
| Cash & equivalents | $128.4M | $69.3M | $75.1M | $93.1M | $203.4M | $288.6M | $181.4M | $192.2M | $100.3M | $90.1M |
| Short-term investments | $180.2M | $384.3M | $179.8M | $368.2M | $136.2M | $133.9M | $165.7M | $163.8M | $39.7M | $23.7M |
| Receivables | $187.8M | $142.1M | $144.2M | $165.5M | $148.9M | $140.9M | $87.3M | $102.9M | $65.6M | $41.5M |
| Inventory | $82.4M | $54.3M | $77.4M | $91.5M | $86.0M | $48.3M | $26.6M | $25.7M | $16.3M | $16.8M |
| Other current assets | $65.3M | $36.1M | $16.7M | $15.8M | $27.0M | $18.7M | $11.6M | $8.9M | $6.5M | $3.0M |
| Total current assets | $644.2M | $686.1M | $493.1M | $734.2M | $601.6M | $630.4M | $472.6M | $493.5M | $228.5M | $151.4M |
| Property, plant & equipment (net) | $10.5M | $11.5M | $13.5M | $15.2M | $17.0M | $37.8M | $17.1M | $4.1M | $5.1M | $4.3M |
| Goodwill & intangible assets | $694.3M | $638.9M | $716.9M | $819.5M | $902.2M | $442.3M | $49.7M | $62.7M | $72.0M | $33.0M |
| Long-term investments | $0 | $0 | $16.6M | $93.9M | $119.2M | $350.4M | $591.8M | $418.8M | $133.6M | $75.4M |
| Other non-current assets | $103.6M | $31.5M | $37.5M | $39.8M | $49.2M | $43.2M | $29.1M | $0 | $0 | $45.4M |
| Total assets | $1.45B | $1.37B | $1.28B | $1.70B | $1.69B | $1.50B | $1.16B | $977.8M | $424.5M | $309.6M |
| Liabilities | ||||||||||
| Accounts payable | $2.7M | $4.6M | $2.0M | $10.5M | $9.3M | $6.1M | $10.1M | $3.2M | $6.8M | $8.1M |
| Short-term debt | $10.6M | $6.9M | $8.3M | $408.8M | $6.5M | $3.8M | $2.8M | $2.2M | $4.3M | $69.4M |
| Deferred revenue | — | — | $1 | $49.8M | $126.2M | $122.4M | $144.4M | −$2.2M | $287,000 | $209,000 |
| Total current liabilities | $338.2M | $292.4M | $290.2M | $688.0M | $315.4M | $245.1M | $160.6M | $161.4M | $123.0M | $80.7M |
| Long-term debt | $0 | $0 | $0 | $0 | $379.3M | $361.8M | $345.2M | $329.5M | $0 | $4.2M |
| Lease obligations | $41.0M | $34.3M | $41.5M | $36.0M | $47.8M | $28.6M | $33.3M | — | — | — |
| Other long-term liabilities | $52.8M | $39.9M | $66.0M | $128.3M | $178.7M | $152.4M | $59.1M | $34.0M | $34.0M | $32.9M |
| Total liabilities | $390.9M | $332.3M | $356.2M | $816.3M | $873.3M | $759.2M | $564.9M | $524.8M | $157.0M | $117.8M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $57,000 | $56,000 | $55,000 | $54,000 | $53,000 | $53,000 | $53,000 | $52,000 | $51,000 | $50,000 |
| Retained earnings (deficit) | $517.9M | $556.4M | $482.6M | $481.2M | $379.9M | $326.5M | $199.5M | $86.5M | −$26.8M | −$84.3M |
| Treasury stock | — | — | — | — | — | — | — | — | $0 | $0 |
| Accumulated other comprehensive income | −$44,000 | −$189,000 | −$593,000 | −$3.2M | $1.5M | $9.0M | $7.4M | −$3.2M | −$747,000 | −$134,000 |
| Minority interest | — | — | — | — | — | — | — | — | $0 | $0 |
| Total shareholders' equity | $1.06B | $1.04B | $921.5M | $886.2M | $815.9M | $744.9M | $595.4M | $453.0M | $267.5M | $191.8M |
| Key figures | ||||||||||
| Total debt | $41.0M | $34.3M | $41.5M | $444.8M | $427.0M | $414.3M | $378.4M | $331.6M | $26.5M | $73.5M |
| Net cash (debt) | $267.7M | $419.3M | $213.3M | $16.6M | −$87.3M | $8.2M | −$31.4M | $24.4M | $113.5M | $16.6M |
| Working capital | $306.0M | $393.7M | $202.9M | $46.2M | $286.2M | $385.3M | $312.1M | $332.1M | $105.5M | $70.7M |
| Tangible book value | $367.4M | $396.8M | $204.6M | $66.7M | −$86.4M | $302.6M | $545.7M | $390.3M | $195.4M | $158.8M |
| Book value per share | $18.81 | $18.51 | $16.60 | $14.37 | $15.01 | $13.87 | $11.06 | $8.37 | $5.02 | $3.71 |
| Shares outstanding | 56.5M | 56.0M | 55.5M | 61.7M | 54.4M | 53.7M | 53.8M | 54.1M | 53.3M | 51.7M |
| Current ratio | 1.90 | 2.35 | 1.70 | 1.07 | 1.91 | 2.57 | 2.94 | 3.06 | 1.86 | 1.88 |
| Quick ratio | 1.47 | 2.04 | 1.38 | 0.91 | 1.55 | 2.30 | 2.71 | 2.84 | 1.67 | 1.63 |
| Debt / equity | 0.04 | 0.03 | 0.05 | 0.50 | 0.52 | 0.56 | 0.64 | 0.73 | 0.10 | 0.38 |
| Equity / assets | 73.1% | 75.7% | 72.1% | 52.1% | 48.3% | 49.5% | 51.3% | 46.3% | 63.0% | 61.9% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $372.1M | $384.2M | $308.7M | $281.2M | $522.6M | $463.6M | $453.6M | $403.2M | $347.2M | $297.7M | $254.9M | $200.2M |
| Cash & equivalents | $180.0M | $184.9M | $128.4M | $151.4M | $144.7M | $115.8M | $69.3M | $31.7M | $52.1M | $63.4M | $75.1M | $95.0M |
| Short-term investments | $192.1M | $199.4M | $180.2M | $129.8M | $377.9M | $347.7M | $384.3M | $371.5M | $295.1M | $234.3M | $179.8M | $105.2M |
| Receivables | $211.7M | $182.2M | $187.8M | $171.3M | $140.8M | $145.6M | $142.1M | $145.4M | $152.5M | $147.7M | $144.2M | $141.8M |
| Inventory | $83.9M | $87.1M | $82.4M | $79.4M | $44.0M | $49.4M | $54.3M | $64.0M | $68.2M | $75.1M | $77.4M | $83.5M |
| Other current assets | $55.8M | $78.1M | $65.3M | $62.1M | $31.4M | $28.9M | $36.1M | $27.4M | $23.2M | $23.8M | $16.7M | $23.9M |
| Total current assets | $723.5M | $731.6M | $644.2M | $593.9M | $738.9M | $687.6M | $686.1M | $640.0M | $591.0M | $544.3M | $493.1M | $449.4M |
| Property, plant & equipment (net) | $35.6M | $36.4M | $10.5M | $10.6M | $11.1M | $11.3M | $11.5M | $11.9M | $12.3M | $13.0M | $13.5M | $13.7M |
| Goodwill & intangible assets | $588.9M | $670.4M | $694.3M | $742.6M | $598.3M | $619.1M | $638.9M | $657.2M | $676.7M | $696.8M | $716.9M | $758.2M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $11.7M | $16.6M | $25.1M |
| Other non-current assets | $80.1M | $62.3M | $103.6M | $72.7M | $34.1M | $29.2M | $31.5M | $33.6M | $35.9M | $38.4M | $37.5M | $38.8M |
| Total assets | $1.43B | $1.50B | $1.45B | $1.42B | $1.38B | $1.35B | $1.37B | $1.34B | $1.32B | $1.30B | $1.28B | $1.29B |
| Liabilities | ||||||||||||
| Accounts payable | $5.6M | $10.2M | $2.7M | $8.2M | $8.2M | $7.1M | $4.6M | $6.4M | $4.6M | $14.4M | $2.0M | $3.4M |
| Short-term debt | $10.7M | $10.6M | $10.6M | $10.8M | $7.4M | $5.9M | $6.9M | $9.2M | $9.7M | $9.1M | $8.3M | $8.5M |
| Deferred revenue | — | — | — | — | — | — | — | −$15.6M | — | — | $1 | $229.1M |
| Total current liabilities | $347.4M | $373.9M | $338.2M | $330.6M | $286.4M | $281.8M | $292.4M | $291.5M | $308.7M | $314.6M | $290.2M | $287.5M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $40.2M | $40.9M | $41.0M | $42.2M | $31.8M | $32.3M | $34.3M | $38.2M | $40.0M | $42.1M | $41.5M | $42.3M |
| Other long-term liabilities | $49.5M | $50.0M | $52.8M | $39.5M | $32.1M | $34.8M | $39.9M | $44.0M | $49.7M | $60.4M | $66.0M | $85.4M |
| Total liabilities | $396.9M | $423.9M | $390.9M | $370.1M | $318.5M | $316.6M | $332.3M | $335.6M | $358.4M | $374.9M | $356.2M | $373.0M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $58,000 | $58,000 | $57,000 | $57,000 | $56,000 | $56,000 | $56,000 | $55,000 | $55,000 | $55,000 | $55,000 | $55,000 |
| Retained earnings (deficit) | $457.2M | $515.6M | $517.9M | $522.0M | $567.1M | $544.6M | $556.4M | $541.1M | $502.6M | $482.7M | $482.6M | $481.4M |
| Accumulated other comprehensive income | −$138,000 | −$255,000 | −$44,000 | −$71,000 | −$200,000 | −$159,000 | −$189,000 | $78,000 | −$372,000 | −$534,000 | −$593,000 | −$1.2M |
| Total shareholders' equity | $1.03B | $1.08B | $1.06B | $1.05B | $1.06B | $1.03B | $1.04B | $1.01B | $957.5M | $929.2M | $921.5M | $912.2M |
| Key figures | ||||||||||||
| Total debt | $40.2M | $40.9M | $41.0M | $42.2M | $31.8M | $32.3M | $34.3M | $38.2M | $40.0M | $42.1M | $41.5M | $42.3M |
| Net cash (debt) | $331.9M | $343.3M | $267.7M | $238.9M | $490.8M | $431.3M | $419.3M | $365.1M | $307.2M | $255.6M | $213.3M | $157.9M |
| Working capital | $376.1M | $357.7M | $306.0M | $263.3M | $452.5M | $405.8M | $393.7M | $348.5M | $282.3M | $229.8M | $202.9M | $161.8M |
| Tangible book value | $442.3M | $406.4M | $367.4M | $307.1M | $465.6M | $411.6M | $396.8M | $350.0M | $280.8M | $232.4M | $204.6M | $154.0M |
| Book value per share | $17.76 | $18.68 | $18.51 | $18.56 | $18.78 | $18.45 | $18.34 | $17.98 | $17.18 | $16.70 | $16.74 | $16.70 |
| Shares outstanding | 58.1M | 57.6M | 57.3M | 56.6M | 56.6M | 55.9M | 56.5M | 56.0M | 55.7M | 55.6M | 55.1M | 54.6M |
| Current ratio | 2.08 | 1.96 | 1.90 | 1.80 | 2.58 | 2.44 | 2.35 | 2.20 | 1.91 | 1.73 | 1.70 | 1.56 |
| Quick ratio | 1.68 | 1.51 | 1.47 | 1.37 | 2.32 | 2.16 | 2.04 | 1.88 | 1.62 | 1.42 | 1.38 | 1.19 |
| Debt / equity | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 |
| Equity / assets | 72.2% | 71.8% | 73.1% | 73.9% | 77.0% | 76.5% | 75.7% | 75.0% | 72.8% | 71.3% | 72.1% | 71.0% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 2, 2026); data from EODHD.
SUPN financial position
At the end of fiscal 2025 (December 31, 2025), Supernus Pharmaceuticals had total assets of $1.5 billion (up 6.2% from a year earlier), total liabilities of $390.9 million and shareholders' equity of $1.1 billion. It held $308.7 million in cash and short-term investments against $41.0 million of debt, a net cash position of $267.7 million. Its current ratio was 1.90. In the latest quarter (ended June 30, 2026) total assets were $1.4 billion and equity $1.0 billion.
Related: SUPN income statement, SUPN cash flow statement, SUPN key metrics. See the SUPN stock overview for the latest quote and news.
SUPN balance sheet FAQ
What are Supernus Pharmaceuticals's total assets?
Supernus Pharmaceuticals reported total assets of $1.5 billion at the end of fiscal 2025 (December 31, 2025), compared with $1.4 billion a year earlier.
How much debt does Supernus Pharmaceuticals have?
Supernus Pharmaceuticals had $41.0 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.04.
How much cash does Supernus Pharmaceuticals have?
Supernus Pharmaceuticals held $308.7 million in cash and short-term investments at the end of fiscal 2025; with $41.0 million of debt that is net cash of $267.7 million.
What is Supernus Pharmaceuticals's book value?
Supernus Pharmaceuticals's shareholders' equity (book value) was $1.1 billion at the end of fiscal 2025, or $18.81 per share.
What is Supernus Pharmaceuticals's current ratio?
Supernus Pharmaceuticals had current assets of $644.2 million and current liabilities of $338.2 million, a current ratio of 1.90 (it can cover its short-term obligations).
How much goodwill does Supernus Pharmaceuticals have?
Supernus Pharmaceuticals carried $694.3 million of goodwill and intangible assets, 47.8% of total assets, at the end of fiscal 2025.